Measurable residual disease in elderly acute myeloid leukemia: Results from the PETHEMA-FLUGAZA phase 3 clinical trial

1. Simoes, C.
2. Paiva, B.
3. Martínez-Cuadrón, D.
4. Bergua, J.-M.
5. Vives, S.
6. Algarra, L.
7. Tormo, M.
8. Martinez, P.
9. Serrano, J.
10. Herrera, P.
11. Ramos, F.
12. Salamero, O.
13. Lavilla, E.
14. Gil, C.
15. Lopez, J.-L.
16. Vidriales, M.-B.
17. Labrador, J.
18. Falantes, J.-F.
19. Sayas, M.-J.
20. Ayala, R.
21. Martinez-Lopez, J.
22. Villar, S.
23. Calasanz, M.-J.
24. Prosper, F.
25. San-Miguel, J.F.
26. Sanz, M.Á.
27. Montesinos, P.
28. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1182/BLOODADVANCES.2020003195 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus